Live feed08:37:31·1492dANALYSTRatingvia QuantisnowWedbush resumed coverage on Global Blood Therapeutics with a new price targetByQuantisnow·Wall Street's wire, on your screen.GBT· Global Blood Therapeutics Inc.Health CareOriginal source